PharmaBoardroom

HIV and AIDS in South Africa

The following chart shows the prevalence of HIV and AIDS in South Africa; a country where 6.3 million people are living with HIV and in which there…

Egyptian Healthcare by Numbers

The following chart provides information on Egyptian healthcare spending, pharma consumption, local production and employment. Click here to…

Interview: Giuseppe Cassisi – CEO, Doppel, Italy

Doppel has been selected as the nucleus for significant investments in the CDMO industry by PE firm Trilantic Capital Partners, according to…

Interview: Andreas Woitossek – Head of Strategy &…

The managing director of Janssen Hungary, Andreas Woitossek, depicts the valuable role of real-world evidence in enabling the affiliate’s consistent…

How Digitalization is Revolutionizing Healthcare

A physician sending off a quick update to a patient via smartphone; a medical caretaker receiving an alert message that a patient’s medical device…

Interview: Martin Minarovič – Managing Director, Janssen…

Janssen Czech Republic’s MD reviews his longstanding career within the company and highlights how founder Dr. Paul Janssen’s legacy still…

Interview: Sergio Liberatore – CEO, IMS Health Italy

Sergio Liberatore discusses IMS Health Italy's evolution after the acquisition of Cegedim’s CRM and strategic data businesses and how IMS is…

Egypt’s Campaign against Viral Hepatitis

As Egypt continues to grapple with the proliferation of the hepatitis C virus, fresh treatment, prevention and market access pathways are now being…

Egyptian Regulatory Reform: “Taming the Beast”

Concerted efforts are, at last, being made to redraw the rulebook and tidy up a local regulatory landscape long renowned for its torpor, dysfunction…

Interview: Abramo Brandi – Managing Director, Octapharma…

Abramo Brandi, Octapharma Italy’s MD, discusses the challenges of the tender system in Italy and how he has grown the company year-on-year in the…

Interview: Mario Marazziti – President of the XII Social…

Mario Marazziti, President of the Italian XII Social Affairs Commission, discusses new legislation relating to clinical risk, the effects of the 2014…

Interview: Luigi Boggio – President, Assobiomedica;…

Luigi Boggio, President of Assobiomedica, the association representing the medtech industry, and MD of B. Braun Italy, calls on the Italian government…

Tagged with